2m 2m 2m 2m 2m 2m 2m
XENETIC BIOSCS (XBIO)
NASDAQ
$2.25+$0.005 (+0.22%)
Price as of Oct 02, 2026 4:10 PM EDT- $5.2MMarket Cap
- -31.91%1-Year Change
- BiotechnologyIndustry
XENETIC BIOSCS (XBIO)
$2.25+$0.005 (+0.22%)
XBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.24 | ||
Change | -$0.08 (-3.45%) | ||
Open | $2.33 | ||
High | $2.33 | ||
Low | $2.21 | ||
Previous Close | $2.32 | ||
Volume | 13,384 | ||
30-Day Average Volume | 168,836 | ||
1-Week Change | -9.31% | ||
1-Month Change | -47.04% | ||
1-Year Change | -31.91% | ||
3-Year Change | -54.29% | ||
5-Year Change | -89.23% | ||
Fundamentals | |||
Shares Outstanding | 2.3M | ||
Total Assets | $7.0M | ||
Market Cap | $5.2M | ||
Enterprise Value | -$1.2M | ||
Period: QTR TTM FY | |||
Revenue | $660,601.00 | ||
Net Income | N/A | ||
Free Cash Flow | -$875,489.00 | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $5.8M | ||
EPS | -$0.41 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | -2 | ||
P/B | N/A | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 05/15/2023 | ||
Earnings & Revenue